Our Strategy

How we performed in FY25 against the iHEALTh strategy

Our Strategy

How we performed in FY25 against the iHEALTh strategy

It is essential to offer all our stakeholders a transparent view of our performance in the final year of the iHEALTh strategy, which ended in March 2025. To achieve this, we need to reflect on our results for FY25.

Reflecting on our performance against the final year of the iHEALTh scorecard and how we added value

The seven SANBS strategic objectives were clearly defined and designed to achieve our vision. Performance against our strategic priorities was measured through defined KPIs incorporated into an overall iHEALTh balanced scorecard which cascaded down to all levels within the organisation.

Innovation

Human-Centred Collections

Excellence in Processes

Administrative Rigour

Logistics Benchmark

Testing and Quality

Hearts and Minds

From 2019–2025: The iHEALTh legacy

Key standout highlights include:

Accreditation excellence

In addition to achieving ISO 9001 accreditation, SANBS maintained 100% SANAS accreditation across all blood bank and donor service sites, emphasising our commitment to quality and consistency

Blood stock stability

We successfully implemented the Whole Blood Group O Programme, achieving the highest number of Group O units collected in the past five years

World-class systems deployed

BECS implementation marked a substantial leap in our technological capabilities

Process automation

Completed (Order-to-Collect phase 1, Procure-to-Pay), freeing teams to focus on care

People-led culture

Transforming our people practices, moving beyond siloed, compliance-driven processes to a truly purpose-led Human Capital model

In the tables below is a summary of our performance for the period ending 31 March 2025 against each component of our iHEALTh scorecard. It also provides a comprehensive view of how we performed for periods ending 2024 and 2023 for comparative purposes.

Performance against strategy

Innovation

Aspiration

Improve and expand current products and services through innovation

Related material matters

Contribution to long-term sustainable value

Strategic priorities

Unlock other revenue streams-enhance services and innovative product mix
Lead the development, commercialisation and delivery of cellular therapies

Target achieved / exceeded

Improvement YOY

No concerns yet

Below target

Key measured initiatives

Initiative	Target	IR 2023	IR 2024	Progress Apr 2024 - Mar 2025
Alternative revenue	R84.58m	R80m Reason: Cellular therapy procedures	R100.4m	R92.05m
#Publications in peer reviewed journals	11	14	14	19
RAD Academy	Address the scarce skills gap and build a future-fit workforce through Growing our Own bursary programme Deepen capacity building efforts across Africa	Further awareness created with internal employees to promote learning and development opportunities	Building a strong partnership with the HPCSA is vital to streamline the accreditation process for Phlebotomist training and address the current skills shortage Excellent progress made with offering digital courses, learning cafés, webinars. An African Transfusion Indaba was hosted with invitees from several African countries	Multiple SANBS blood bank laboratories await full HPCSA accreditation. As audits and approvals lag, trainees, including laboratory assistants and medical technologists, cannot complete their required practical training in blood-bank settings SANBS continues to strengthen relationships with HPCSA and SANC to resolve accreditation and training bottlenecks for technologists and phlebotomists Hosted African Transfusion Indaba and hosted a delegation from Ethiopia for specialised stem cell collection training
Drone Project	Project plan	Not live due to delays in CAA approvals. CAA approval has been granted for one route only	The project team faces significant challenges in getting drones operational due to regulatory hurdles	A decision was made to pause the drone logistics project, driven by high operational costs and regulatory hurdles
BECS Implementation	Project plan	Implementation delays	BECS went live in November 2023, a significant milestone for SANBS in progressing its digital transformation agenda	The project has transitioned to full maintenance mode. Any remaining issues are managed as new requests
SARS-CoV-2 sero-prevalence study	Complete study	Study complete and being submitted to peer reviewed journal	Data collection and analysis is ongoing	Procurement of an Epidemiologist was concluded and data quality control and analysis took place during the period
Smart fridges	Project plan	First smart fridge operationalised	Placement of additional smart fridges requires individual interfacing into BECS as well as ensuring reliable connectivity	A new haemobank SMART fridge is currently undergoing testing for 3G/4G connectivity stability Successful validation will pave the way for further roll-out to key hospitals nationwide

Human centred collections

It takes more than one heart to save a life. At SANBS, we serve with heart, together with every donor, every colleague, and every life touched by our mission.